According to the new research report available at MarketStudyReport.com under the title ‘Biological Safety Testing Market, By Products and Services (Products {Kits and Reagents, Instruments}, Services), By Test (Endotoxin Test, Sterility Test, Adventitious Agent Detection Test), By Application (Blood & Blood-based Products, Vaccines & Therapeutics, Stem Cells), By End-use (Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Companies, Research and Academia), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, the global biological safety testing market is anticipated to surpass USD 4.5 billion by the year 2025.
 

The demand of biological safety testing market is propelled by factors such as increase in number of drug discovery research activities for the treatment of broad range of serious disorders, government initiatives and symposiums promote biologics safety testing. These tests help in minimizing contamination and optimizing manufacturing procedures.
 

Moreover, implementation of biological safety testing for microbe-free and safe production of biologics and pharmaceutical products, along with the need for minimizing the risk of healthcare associated infections will further aid the market growth.
 

The report cites that biological safety testing services market is presumed to grow with a CAGR of 12.4% in upcoming years, as these services enables the biologics manufacturers in reducing cost burden. The service providers offer customized services as per product requirement, and are focusing on expanding business by setting-up new facilities, hence aiding the market growth.
 

Based on test types, biological safety testing market from endotoxin test segment registered 23% revenue share in 2018, owing to its extensive application for determining the presence of pyrogen and total microbial burden to ensure safety of biologics for human use.
 

Speaking of application spectrum, biological safety testing market from stem cells segment is articulated to register a decent growth over the forecast period, pertaining to increasing cases of arthritis, congenital disorders, and autoimmune diseases. The report states that growing application of stem cells in regenerative medicine is aiding the market expansion.
 

In terms of end-use spectrum, biological safety testing market from pharmaceutical & biotechnology companies are slated to expand significantly in the upcoming years. As new market entrants offer novel therapeutics, and established firms have drugs in preclinical phase, the demand for biological safety testing will further escalate.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2337490/
 

Considering the regional landscape, Canada biological safety testing market held over USD 81 million in 2018 and is predicted to dominate the market in the coming years, owing to escalating manufacturing facilities as well as favorable government initiatives for expansion of vaccine and pharmaceutical industry across the region.   
 

Some of the vendors that operate in biological safety testing market are Sartorius AG, Promega Corporation, Toxikon, WuXi Biologics, Pharmabiotic Corporation, Thermo Fisher Scientific, SGS SA, Charles River, Lonza, Merck KGaA, and Eurofins Scientific.